CLINICAL_TRIALS
trial_result
· 2024-08-09
Clinical Trial Update: A Study of Brexpiprazole in Patients With Major Depressive Disorder [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 study evaluating brexpiprazole in adults with major depressive disorder has completed, with results posted on 2024-08-09.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-08-09